Bone turnover rate and bone formation/resorption balance during the early stage after switching from a bone resorption inhibitor to denosumab are predictive factors of bone mineral density change. [electronic resource]
- Osteoporosis and sarcopenia Mar 2017
- 45-52 p. digital